CONRIG PHARMA ApS: Financial statements 2016
CVR: 33373236
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -683,941 and a net result of DKK -530,670 compared with DKK -73,599 the year before. Equity in the 2016 report amounted to DKK 89,797. The solvency ratio was 32.9%.
- Gross Profit
- DKK -683,941
- Profit/Loss
- DKK -530,670
- Equity
- DKK 89,797
- Total Assets
- DKK 272,628
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | -684 t. | -531 t. | 90 t. | - |
| 2015 | - | -89 t. | -74 t. | 620 t. | - |
| 2014 | - | -93 t. | -81 t. | 94 t. | - |
| 2013 | - | -228 t. | -274 t. | 276 t. | - |
| 2012 | - | -266 t. | -244 t. | 200 t. | - |
Find more companies like CONRIG PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
CONRIG PHARMA ApS has published its annual report for 2015. Gross profit came to DKK -88,540, and the net result was DKK -73,599.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.